pre-seed
Stage
2023
Founded
1
Investors
About
Transient Pharma AB develops innovative systemic anti-inflammatory treatments, focusing initially on gastrointestinal inflammatory disorders and curbing excessive inflammation during acute infections, with a proprietary peptide called TIM-03 showing strong anti-inflammatory and antimicrobial effects.
Explore Transient Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.